![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Gedeon Richter Plc Budapest Hu, based in Hungary, is a pharmaceutical company.
One of their significant offerings is Paroxetine hydrochloride hemihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-250 - Rev 02
This Chemical Type CEP, issued on July 28, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2018 associated with this CEP further emphasizes